Clinical trial
The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
NCT00422058 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00422058 |
|---|---|
| Title | The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes |
| Official title | Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes: A 20-week Randomised, Double-blind, Placebo-controlled, Six Armed Parallel Group, Multi-centre, Multinational Trial With an Open Label Orlistat Comparator Arm and With an 84-week Extension Period |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metabolism and Nutrition Disorder, Obesity |
| Intervention type | Drug |
| Interventions | liraglutide, orlistat, placebo |
| Enrollment | 564 |
| Start date | Jan 10, 2007 |
| Primary completion | Sep 13, 2007 |
| Completion | Apr 30, 2009 |
| First posted | Jan 15, 2007 |
| Last update posted | Nov 1, 2017 |
| Countries | Belgium, Czechia, Denmark, Finland, Netherlands, Spain, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: